
Hands-On Generative AI using real-world applications
Generative AI (GenAI), involves harnessing AI capabilities to produce new
Explore the frontier of digital business enablement and outcomes. Here, you’ll find expert insights and perspectives from Altimetrians across the globe.
Generative AI (GenAI), involves harnessing AI capabilities to produce new
What is the Framework? The Framework is voluntary guidance, based
Introduction “Business Email Compromise” (BEC) represents a significant threat in
Currently, Sonarqube is not supported on EKS. There is documentation
Through this Academy, Altimetrik aims to enable enterprises to create
In a recent interview, Raj, a key figure at Altimetrik,
Jayaprakash Nair, a contributor to the Techstong.ai article titled “Smartling
On International Women in Engineering Day, Techgig had an exclusive
Data Automation Is on the Rise
Tech professionals return to IT companies
‘Official yet?’: Has time come to end work-from-home?
How digital tech is helping to merge online & offline
In the fast-paced realm of modern business, striking a crucial
Altimetrik presents an innovative approach that places efficiency, precision, and
The Department of Homeland Security (DHS), alongside the Cybersecurity and
Leveraging the strengths and overcoming limitations of GenAI Generative AI
The client, a renowned global banking institution operating in over
The client is one of the world’s largest banking organizations
The financial industry is increasingly relying on technology to provide
The client is one of the largest growers of premium
Adaptive Clinical Trial Designs: Modify trials based on interim results for faster identification of effective drugs. | Identify effective drugs faster with data analytics and machine learning algorithms to analyze interim trial results and modify. |
Real-World Evidence (RWE) Integration: Supplement trial data with real-world insights for drug effectiveness and safety. | Supplement trial data with real-world insights for drug effectiveness and safety. |
Biomarker Identification and Validation: Validate biomarkers predicting treatment response for targeted therapies. | Utilize bioinformatics and computational biology to validate biomarkers predicting treatment response for targeted therapies. |
Collaborative Clinical Research Networks: Establish networks for better patient recruitment and data sharing. | Leverage cloud-based platforms and collaborative software to establish networks for better patient recruitment and data sharing. |
Master Protocols and Basket Trials: Evaluate multiple drugs in one trial for efficient drug development. | Implement electronic data capture systems and digital platforms to efficiently manage and evaluate multiple drugs or drug combinations within a single trial, enabling more streamlined drug development |
Remote and Decentralized Trials: Embrace virtual trials for broader patient participation. | Embrace telemedicine, virtual monitoring, and digital health tools to conduct remote and decentralized trials, allowing patients to participate from home and reducing the need for frequent in-person visits |
Patient-Centric Trials: Design trials with patient needs in mind for better recruitment and retention. | Develop patient-centric mobile apps and web portals that provide trial information, virtual support groups, and patient-reported outcome tracking to enhance patient engagement, recruitment, and retention |
Regulatory Engagement and Expedited Review Pathways: Engage regulators early for faster approvals. | Utilize digital communication tools to engage regulatory agencies early in the drug development process, enabling faster feedback and exploration of expedited review pathways for accelerated approvals |
Companion Diagnostics Development: Develop diagnostics for targeted recruitment and personalized treatment. | Implement bioinformatics and genomics technologies to develop companion diagnostics that can identify patient subpopulations likely to benefit from the drug, aiding in targeted recruitment and personalized treatment |
Data Standardization and Interoperability: Ensure seamless data exchange among research sites. | Utilize interoperable electronic health record systems and health data standards to ensure seamless data exchange among different research sites, promoting efficient data aggregation and analysis |
Use of AI and Predictive Analytics: Apply AI for drug candidate identification and data analysis. | Leverage AI algorithms and predictive analytics to analyze large datasets, identify potential drug candidates, optimize trial designs, and predict treatment outcomes, accelerating the drug development process |
R&D Investments: Improve the drug or expand indications | Utilize computational modelling and simulation techniques to accelerate drug discovery and optimize drug development processes |
Adding {{itemName}} to cart
Added {{itemName}} to cart